- Report
- July 2024
- 140 Pages
Global
From €5415EUR$5,950USD£4,642GBP
- Report
- April 2025
- 179 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 373 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- April 2025
- 284 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 131 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 134 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Report
- May 2024
- 133 Pages
Global
From €5915EUR$6,499USD£5,071GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Clinical Trials
- December 2024
- 60 Pages
Global
From €1365EUR$1,500USD£1,170GBP
- Report
- April 2025
- 185 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- November 2021
- 295 Pages
Global
From €2503EUR$2,750USD£2,146GBP
€5006EUR$5,500USD£4,291GBP
- Report
- May 2021
- 70 Pages
United States
From €774EUR$850USD£663GBP
- Report
- September 2023
- 100 Pages
Global
From €5415EUR$5,950USD£4,642GBP

Itraconazole is an antifungal medication used to treat a variety of fungal infections, including those caused by Aspergillus, Blastomyces, Coccidioides, Histoplasma, and Candida species. It is commonly used to treat infections of the skin, nails, and lungs, as well as systemic fungal infections. Itraconazole is available in both oral and intravenous formulations.
Itraconazole is a key component of the infectious diseases drugs market, as it is used to treat a wide range of fungal infections. It is often used in combination with other antifungal medications, such as fluconazole and amphotericin B, to provide a more comprehensive treatment. Itraconazole is also used to prevent fungal infections in patients who are immunocompromised or have a weakened immune system.
The Itraconazole market is highly competitive, with a number of major pharmaceutical companies offering their own formulations of the drug. Some of the major players in the market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more